High content screening in neurodegenerative diseases

Area of Science:

• Neuroscience
• Genomics
• Drug Discovery

Background:

• Neurodegenerative diseases pose urgent challenges for genome annotation, molecular network construction, and drug target identification.
• Current 'omics' approaches identify genetic risk factors but require functional validation, often hindered by slow traditional methods.
• Understanding complex molecular networks and disease phenotypes necessitates advanced screening techniques beyond traditional high-throughput screening (HTS).

Purpose of the Study:

• To develop and validate a method for accurate and reliable shRNA screening in neuronal models using automated cell culturing and high-content (HC) imaging.
• To identify modulators of the DJ1 protein, a key factor in autosomal recessive parkinsonism.
• To leverage high-throughput (HT) and HC imaging for comprehensive phenotyping to advance understanding of disease pathways and therapeutic targets.

Main Methods:

• Development of an automated cell culturing system for neuronal models.
• Implementation of high-content (HC) imaging for multi-dimensional phenotyping.
• Conducting shRNA screens to identify modulators of the DJ1 protein.

Main Results:

• A robust method for conducting HT-HC screens in neuronal models was established, reducing variation and increasing sensitivity.
• The methodology successfully identified modulators for the DJ1 protein, implicated in Parkinson's disease.
• Demonstrated the capability of HC imaging to quantify numerous phenotypes crucial for understanding disease pathogenesis.

Conclusions:

• Automated cell culturing combined with HC imaging provides a sensitive and reproducible platform for phenomic-scale cellular response detection.
• This integrated approach accelerates the functional validation of genetic findings and the identification of novel therapeutic targets for neurodegenerative diseases.
• The developed methodology advances the understanding of complex disease pathways and facilitates the discovery of more effective drug interventions.